AAAAAA

   
Results: 1-8 |
Results: 8
Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL)
Authors: Najjar, F Hustinx, R Jerusalem, G Fillet, G Rigo, P
Citation: F. Najjar et al., Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL), CANC BIO R, 16(4), 2001, pp. 297-304
Positron emission tomography (PET) with F-18-fluorodeoxyglucose (F-18-FDG)for the staging of low-grade non-Hodgkin's lymphoma (NHL)
Authors: Jerusalem, G Beguin, Y Najjar, F Hustinx, R Fassotte, MF Rigo, P Fillet, G
Citation: G. Jerusalem et al., Positron emission tomography (PET) with F-18-fluorodeoxyglucose (F-18-FDG)for the staging of low-grade non-Hodgkin's lymphoma (NHL), ANN ONCOL, 12(6), 2001, pp. 825-830
Whole-body positron emission tomography using F-18-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease
Authors: Jerusalem, G Beguin, Y Fassotte, MF Najjar, F Paulus, P Rigo, P Fillet, G
Citation: G. Jerusalem et al., Whole-body positron emission tomography using F-18-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease, HAEMATOLOG, 86(3), 2001, pp. 266-273
Persistent tumor F-18-FDG uptake after a few cycles of polychemotherapy ispredictive of treatment failure in non-Hodgkin's lymphoma
Authors: Jerusalem, G Beguin, Y Fassotte, MF Najjar, F Paulus, P Rigo, P Fillet, G
Citation: G. Jerusalem et al., Persistent tumor F-18-FDG uptake after a few cycles of polychemotherapy ispredictive of treatment failure in non-Hodgkin's lymphoma, HAEMATOLOG, 85(6), 2000, pp. 613-618
Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+cells and/or CFU-GM with chemotherapy and G-CSF
Authors: Fraipont, V Sautois, B Baudoux, E Pereira, M Fassotte, MF Hermanne, JP Jerusalem, G Longree, L Schaaf-Lafontaine, N Fillet, G Beguin, Y
Citation: V. Fraipont et al., Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+cells and/or CFU-GM with chemotherapy and G-CSF, TRANSFUSION, 40(3), 2000, pp. 339-347
Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields
Authors: Sautois, B Fraipont, V Baudoux, E Fassotte, MF Hermanne, JP Jerusalem, G Bours, V Bosquee, L Schaaf-Lafontaine, N Paulus, JM Sondag, D Fillet, G Beguin, Y
Citation: B. Sautois et al., Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields, HAEMATOLOG, 84(4), 1999, pp. 342-349
Whole-body F-18-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphoma
Authors: Jerusalem, G Warland, V Najjar, F Paulus, P Fassotte, MF Fillet, G Rigo, P
Citation: G. Jerusalem et al., Whole-body F-18-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphoma, NUCL MED C, 20(1), 1999, pp. 13-20
Whole-body positron emission tomography using F-18-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomographyscan imaging
Authors: Jerusalem, G Beguin, Y Fassotte, MF Najjar, F Paulus, P Rigo, P Fillet, G
Citation: G. Jerusalem et al., Whole-body positron emission tomography using F-18-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomographyscan imaging, BLOOD, 94(2), 1999, pp. 429-433
Risultati: 1-8 |